Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-7011

Single-particle
35.0 Å
EMD-7011
3D View Gallery
Deposition: 04/09/2017
Map released: 01/11/2017
Last modified: 13/03/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-7011
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 6avq summary report (pdf.gz) Map and 6avq FULL report (pdf.gz)
EMICSS annotations (xml)

The Therapeutic Antibody LM609 Selectively Inhibits Ligand Binding to Human alpha-V beta-3 Integrin via Steric Hindrance

EMD-7011

Single-particle
35.0 Å
EMD-7011
3D View Gallery
Deposition: 04/09/2017
Map released: 01/11/2017
Last modified: 13/03/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Mus musculus
Sample: Quaternary complex of human alpha-V beta-3 integrin with the Fab LM609
Fitted models: 6avq

Deposition Authors: Borst AJ , James ZN
The Therapeutic Antibody LM609 Selectively Inhibits Ligand Binding to Human alpha V beta 3 Integrin via Steric Hindrance.
Borst AJ , James ZM, Zagotta WN, Ginsberg M, Rey FA , DiMaio F, Backovic M , Veesler D
(2017) Structure , 25 , 1732 - 1739.e5
PUBMED: 29033288
DOI: doi:10.1016/j.str.2017.09.007
ISSN: 1878-4186
ASTM: STRUE6